Angelo Sangiovanni

10.3k total citations · 2 hit papers
124 papers, 6.1k citations indexed

About

Angelo Sangiovanni is a scholar working on Hepatology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Angelo Sangiovanni has authored 124 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Hepatology, 76 papers in Epidemiology and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Angelo Sangiovanni's work include Liver Disease Diagnosis and Treatment (66 papers), Hepatocellular Carcinoma Treatment and Prognosis (59 papers) and Liver Disease and Transplantation (31 papers). Angelo Sangiovanni is often cited by papers focused on Liver Disease Diagnosis and Treatment (66 papers), Hepatocellular Carcinoma Treatment and Prognosis (59 papers) and Liver Disease and Transplantation (31 papers). Angelo Sangiovanni collaborates with scholars based in Italy, United States and Spain. Angelo Sangiovanni's co-authors include E. Del Ninno, Massimo Colombo, R. Romeo, Roberto de Franchis, Massimo Iavarone, Guido Ronchi, Cristina De Fazio, Pierangelo Fasani, M. Colombo and Massimo Colombo and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Angelo Sangiovanni

117 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial

2012 656 citations Angelo Sangiovanni, Josep M. Llovet et al. Journal of Hepatology profile →
Hepatocellular Carcinoma in Italian Patients with Cirrhosis

1991 649 citations Massimo Colombo, Angelo Sangiovanni et al. profile →

Peers

Countries citing papers authored by Angelo Sangiovanni

Since Specialization

Citations

This map shows the geographic impact of Angelo Sangiovanni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelo Sangiovanni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelo Sangiovanni more than expected).

Fields of papers citing papers by Angelo Sangiovanni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angelo Sangiovanni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelo Sangiovanni. The network helps show where Angelo Sangiovanni may publish in the future.

Co-authorship network of co-authors of Angelo Sangiovanni

This figure shows the co-authorship network connecting the top 25 collaborators of Angelo Sangiovanni. A scholar is included among the top collaborators of Angelo Sangiovanni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angelo Sangiovanni. Angelo Sangiovanni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A modified Charlson Comorbidity Index to improve management of patients with hepatocellular carcinoma: a step towards precision medicine 2024 ·Digestive and Liver Disease ·(unknown), Massimo Iavarone, (unknown), (unknown), Barbara Antonelli, Anna Maria Ierardi, S. Crespi, (unknown), Angelo Sangiovanni, Pietro Lampertico	0
2	Impact of Sarcopenia on the Survival of Patients with Hepatocellular Carcinoma Treated with Sorafenib 2024 ·Cancers ·Maurizio Biselli, (unknown), Massimo Iavarone, Matteo Renzulli, (unknown), Alessandro Granito, Fabio Piscaglia, Stefania Lorenzini, (unknown), Giulio Vara, Paolo Caraceni, Angelo Sangiovanni, Massimo Marignani, Elia Gigante, Nicolò Brandi, Annagiulia Gramenzi, Franco Trevisani	2
3	Virtual Treatment Zone From Cone Beam CT Commonly Alters Treatment Plan and Identifies Tumor at Risk for Under-Treatment in US or US Fusion-Guided Microwave Ablation of Liver Tumors 2023 ·Technology in Cancer Research & Treatment ·(unknown), Anna Maria Ierardi, Alessandro Caruso, (unknown), Letizia Di Meglio, Pierpaolo Biondetti, Massimo Iavarone, Angelo Sangiovanni, Salvatore Alessio Angileri, Chiara Floridi, Bradford J. Wood, Gianpaolo Carrafiello	0
4	Management of Non-Melanoma Skin Cancer: Radiologists Challenging and Risk Assessment 2023 ·Diagnostics ·(unknown), Anna Russo, Fabrizio Urraro, Fabrizio Cioce, (unknown), Maria Paola Belfiore, Angelo Sangiovanni, Stefania Napolitano, Teresa Troiani, (unknown), Antonello Sica, Gabriella Brancaccio, (unknown), Valerio Nardone, Alfonso Reginelli	7
5	Radiotherapy and Chemotherapy Features in the Treatment for Locoregional Recurrence of Endometrial Cancer: A Systematic Review 2023 ·Journal of Personalized Medicine ·Carlo Ronsini, Irene Iavarone, (unknown), (unknown), Pasquale De Franciscis, Angelo Sangiovanni, Luigi Della Corte	6
6	Clinical Impact of a Protocol Involving Cone-Beam CT (CBCT), Fusion Imaging and Ablation Volume Prediction in Percutaneous Image-Guided Microwave Ablation in Patients with Hepatocellular Carcinoma Unsuitable for Standard Ultrasound (US) Guidance 2023 ·Journal of Clinical Medicine ·Pierpaolo Biondetti, Anna Maria Ierardi, Elena Casiraghi, Alessandro Caruso, (unknown), Serena Carriero, Carolina Lanza, Salvatore Alessio Angileri, Angelo Sangiovanni, Massimo Iavarone, Giuseppe Guzzardi, Gianpaolo Carrafiello	1
7	Residual burden of liver disease after HCV clearance in hemophilia: a word of caution in the era of gene therapy 2023 ·Blood Advances ·Vincenzo La Mura, (unknown), (unknown), (unknown), Simona Maria Siboni, (unknown), Alessandro Ciavarella, Roberta Gualtierotti, Anna Ludovica Fracanzani, Angelo Sangiovanni, Flora Peyvandi	11
8	A Trimodality, Four-Step Treatment including Chemotherapy, Pleurectomy/Decortication and Radiotherapy in Early-Stage Malignant Pleural Mesothelioma: A Single-Institution Retrospective Case Series Study 2021 ·Cancers ·Giovanni Vicidomini, Carminia Maria Della Corte, (unknown), Raimondo Di Liello, Salvatore Cappabianca, Alfonso Fiorelli, Valerio Nardone, Gaetana Messina, Giuseppe Viscardi, Angelo Sangiovanni, Riccardo Monti, Marina Accardo, Floriana Morgillo, Fortunato Ciardiello, Renato Franco, Mario Santini	3
9	Feasibility of stereotactic ablative reirradiation in breast cancer patient undergoing palbociclib: a case report 2021 ·Iranian Journal of radiation research ·Valerio Nardone, Alfonso Reginelli, Claudio Vitale, (unknown), Pierpaolo Correale, Roberta Grassi, Sara Falivene, Angelo Sangiovanni, Salvatore Cappabianca, Cesare Guida	0
10	Sarcopenia is associated with reduced survival in patients with advanced hepatocellular carcinoma undergoing sorafenib treatment 2018 ·United European Gastroenterology Journal ·Giulio Antonelli, Elia Gigante, Massimo Iavarone, Paola Begini, Angelo Sangiovanni, Elsa Iannicelli, (unknown), Adriano Pellicelli, L. Miglioresi, Paolo Marchetti, Pietro Lampertico, Massimo Marignani	51
11	Clinical features and outcomes of hepatocellular carcinoma in Caucasian cirrhotic patients on long‐term analogue therapy for hepatitis B 2018 ·Alimentary Pharmacology & Therapeutics ·Alessandro Loglio, Massimo Iavarone, G. Grossi, Mauro Viganò, Maria Grazia Rumi, F. Facchetti, G. Lunghi, Angelo Sangiovanni, M. Colombo, Pietro Lampertico	5
12	Performance status versus anatomical recovery in metastatic disease: The role of palliative radiation treatment 2016 ·International Journal of Surgery ·Alfonso Reginelli, Giustino Silvestro, (unknown), Angelo Sangiovanni, (unknown), I. Nuzzo, (unknown), (unknown), Roberta Grassi, (unknown), Salvatore Cappabianca	8
13	A hepatic stellate cell gene expression signature associated with outcomes in hepatitis C cirrhosis and hepatocellular carcinoma after curative resection 2015 ·Gut ·(unknown), Nicolas Goossens, Guo J, Ming‐Chao Tsai, (unknown), (unknown), Angelo Sangiovanni, Massimo Iavarone, M. Colombo, Masahiro Kobayashi, Hiromitsu Kumada, Augusto Villanueva, Josep M. Llovet, Yujin Hoshida, Scott L. Friedman	92
14	Early diagnosis of liver cancer: an appraisal of international recommendations and future perspectives 2015 ·Liver International ·C. Della Corte, M. Triolo, Massimo Iavarone, Angelo Sangiovanni	18
15	722 LIVER STIFFNESS AND HEPATOCELLULAR CARCINOMA: IS IT REALLY USEFUL? 2013 ·Journal of Hepatology ·Sara Massironi, Rosario Rossi, Mirella Fraquelli, Angelo Sangiovanni, Massimo Iavarone, M. Colombo, D. Conte	2
16	Prognostic Gene Expression Signature for Patients With Hepatitis C–Related Early-Stage Cirrhosis 2013 ·Gastroenterology ·Yujin Hoshida, Augusto Villanueva, Angelo Sangiovanni, Manel Solé, Chin Hur, Karin L. Andersson, Raymond T. Chung, Joshua Gould, Kensuke Kojima, Supriya Gupta, Bradley Taylor, Andrew Crenshaw, Stacey Gabriel, Beatriz Mínguez, Massimo Iavarone, Scott L. Friedman, Massimo Colombo, Josep M. Llovet, Todd R. Golub	158
17	Interferon alfa treatment of HCV RNA carriers with persistently normal transaminase levels: A pilot randomized controlled study 1998 ·Hepatology ·Angelo Sangiovanni, (unknown), Giancarlo Spinzi, Maria Grazia Rumi, (unknown), Roberto Ceriani, Enrico Colombo, (unknown), Alberto Prada, E Tavani, Giorgio Minoli	73
18	Prevalence and incidence of cholelithiasis in patients with liver cirrhosis. 1997 ·PubMed ·Adriana Maggi, (unknown), (unknown), G. Borroni, M. Cazzaniga, Angelo Sangiovanni, (unknown), Francesco Salerno	28
19	High doses of Senna for colon cleansing 1996 ·Gianfranco Frigerio, G. Imperiali, Nicoletta Lenoci, Angelo Sangiovanni, Giancarlo Spinzi, Enrico Strocchi, Vittorio Terruzzi, Giorgio Minoli	7
20	β-blockade prevents recurrent gastrointestinal bleeding in well-compensated patients with alcoholic cirrhosis: A multicenter randomized controlled trial 1989 ·Hepatology ·Massimo Colombo, Roberto de Franchis, Maurizio Tommasini, Angelo Sangiovanni, N Dioguardi	83

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact